BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26299585)

  • 1. Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel.
    Fujii M; Takahashi I; Honma M; Ishida-Yamamoto A
    J Dermatol; 2015 Nov; 42(11):1134-5. PubMed ID: 26299585
    [No Abstract]   [Full Text] [Related]  

  • 2. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

  • 3. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
    Story SG; Beschloss JK; Dolan CK; Thomas BC
    J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
    [No Abstract]   [Full Text] [Related]  

  • 4. Eccrine squamous syringometaplasia in intertriginous areas.
    Valks R; Buezo GF; Daudén E; Fraga J; García-Díez A
    Br J Dermatol; 1996 May; 134(5):984-6. PubMed ID: 8736357
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxic erythema of chemotherapy: a useful clinical term.
    Bolognia JL; Cooper DL; Glusac EJ
    J Am Acad Dermatol; 2008 Sep; 59(3):524-9. PubMed ID: 18694683
    [No Abstract]   [Full Text] [Related]  

  • 6. Antineoplastic chemotherapy, sweat, and the skin.
    Horn TD
    Arch Dermatol; 1997 Jul; 133(7):905-6. PubMed ID: 9236531
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy-induced eccrine squamous syringometaplasia. A distinctive eruption in patients receiving hematopoietic progenitor cells.
    Valks R; Fraga J; Porras-Luque J; Figuera A; Garcia-Diéz A; Fernändez-Herrera J
    Arch Dermatol; 1997 Jul; 133(7):873-8. PubMed ID: 9236526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Strip-shaped erythema under polychemotherapy].
    Nilles N; Kneisel A; Bender A; Hertl M
    J Dtsch Dermatol Ges; 2010 Oct; 8(10):849-50. PubMed ID: 20883383
    [No Abstract]   [Full Text] [Related]  

  • 9. Imatinib-induced eccrine squamous syringometaplasia.
    Van de Voorde K; De Raeve H; Van Regenmortel N; Lambert J
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S58-9. PubMed ID: 16843129
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eccrine squamous syringometaplasia from chemotherapy extravasation].
    Bordel MT; Miranda A
    Actas Dermosifiliogr; 2005 Sep; 96(7):462-4. PubMed ID: 16476276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A striking, localized eruption.
    Tschetter AJ; Stone MS; VanBeek MJ
    JAMA Dermatol; 2014 Nov; 150(11):1229-30. PubMed ID: 25271912
    [No Abstract]   [Full Text] [Related]  

  • 12. Eccrine squamous syringometaplasia in chemotherapy-induced acral erythema.
    Rongioletti F; Rebora A
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):284. PubMed ID: 1552086
    [No Abstract]   [Full Text] [Related]  

  • 13. Vemurafenib-induced eccrine squamous syringometaplasia.
    Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
    Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications.
    Kudlowitz D; Muggia F
    Expert Opin Drug Saf; 2014 Jun; 13(6):681-5. PubMed ID: 24749649
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological features.
    Martorell-Calatayud A; Sanmartín O; Botella-Estrada R; Balmer NN; Serra-Guillén C; Gomez-Moyano E; Traves-Zapata V; Requena C; Nagore E; Llombart-Cussac B; Guillen-Barona C
    J Am Acad Dermatol; 2011 Jun; 64(6):1092-103. PubMed ID: 21489654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature.
    Tsuboi H; Yonemoto K; Katsuoka K
    J Dermatol; 2005 Nov; 32(11):921-5. PubMed ID: 16361756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced eccrine squamous syringometaplasia in an infant.
    Bittar PG; Casady M; Selim MA; Prose NS
    Pediatr Dermatol; 2018 Jan; 35(1):e84-e85. PubMed ID: 29231256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eccrine squamous syringometaplasia secondary to pegylated liposomal doxorubicin.
    Garcia-Navarro X; Puig L; Fernández-Figueras MT; Alomar A
    Arch Dermatol; 2008 Oct; 144(10):1402-3. PubMed ID: 18936417
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrotizing eccrine squamous syringometaplasia presenting as acral erythema.
    Rongioletti F; Ballestrero A; Bogliolo F; Rebora A
    J Cutan Pathol; 1991 Dec; 18(6):453-6. PubMed ID: 1774355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
    Kupfer I; Balguerie X; Courville P; Chinet P; Joly P
    J Am Acad Dermatol; 2003 Feb; 48(2):279-81. PubMed ID: 12582404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.